Advances in Corticosteroid Therapy for Ocular Inflammation: Loteprednol Etabonate

<table>Mean (SEM) IOP for subjects receiving loteprednol etabonate and prednisolone. Within-treatment significant changes from baseline are indicated adapted from [<a href="/journals/iji/2012/789623/#B50">50</a>].</table>

International Journal of Inflammation

fig5

Figure 5

Figure 5: Advances in Corticosteroid Therapy for Ocular Inflammation: Loteprednol Etabonate 